Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
- 1 August 1993
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 20 (8), 716-731
- https://doi.org/10.1007/bf00181765
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- A case of antibody formation against octreotide visualized with 111In‐octreotide scintigraphyClinical Endocrinology, 1993
- Somatostatin receptor imaging of endocrine gastrointestinal tumors.1992
- Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth.Journal of Clinical Endocrinology & Metabolism, 1992
- Rezeptorszintigraphie bei endokrinen gastroenteropankreatischen Tumoren*Deutsche Medizinische Wochenschrift (1946), 1992
- In VivoDetection of Somatostatin Receptors in Patients with Functionless Pituitary Adenomas by Means of a Radioiodinated Analog of Somatostatin ([123I]SDZ 204–090)*Journal of Clinical Endocrinology & Metabolism, 1991
- Effects of antibodies against octreotide in two patients with acromegalyClinical Endocrinology, 1991
- Common tumors of the parapharyngeal space: refined imaging diagnosis.Radiology, 1988
- Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitaryNeuroscience, 1985
- Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.Gut, 1985
- Quantitative Electron Microscopic Autoradiography of Insulin, Glucagon, and Somatostatin Binding Sites on IsletsScience, 1982